Spironolactone
Formulations: - Oral > Liquid: 25 mg per 5 mL Oral > Solid > tablet: 25 mg; 12.5 mg - Oral > Solid > tablet: 25 mg Indications: - Oedema - Ascites - Heart failure Source: EML workbook import
MOQ: 1
Price on request
Catalogue
Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.
All Products (Showing 204 out of 662)
Torasemide
Indications: - Anuria or oliguria - Oedema - Heart failure Source: EML workbook import
MOQ: 1
Price on request
Acetic Acid
Formulations: - Local > Otological > drops: 2% solution Indications: - Infectious diseases of external ear Source: EML workbook import
MOQ: 1
Price on request
Ciprofloxacin
Formulations: - Parenteral > General injections > IV: 2 mg per mL (as hyclate) Oral > Liquid: 250 mg per 5 mL (anhydrous) Oral > Solid: 250 mg (as hydrochloride) Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride) Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride) Indications: - Acute pyelonephritis (mild to moderate) - Infectious gastroenteritis or colitis without specification of infectious agent - Paratyphoid fever - Typhoid fever - Neutropenia (low-risk) - Inflammatory and other diseases of prostate (mild to moderate) - Cholera - Cholera [children] - Peritonitis (mild-moderate) - Peritoneal abscess (mild-moderate) - Bacterial infection of unspecified site Source: EML workbook import
MOQ: 1
Price on request
Ofloxacin
Formulations: - Local > Ophthalmological > Solution (eye drops): 0.3% Indications: - Other specified conjunctivitis - Infectious keratitis Source: EML workbook import
MOQ: 1
Price on request
Xylometazoline
Formulations: - Local > Nasal > Spray: 0.05% equivalent to 0.5 mg per mL Local > Nasal > Drops: 0.05% equivalent to 0.5 mg per mL Indications: - Nasal congestion Source: EML workbook import
MOQ: 1
Price on request
Acetylsalicylic Acid + Atorvastatin + Ramipril
Formulations: - Oral > Solid > tablet: 100 mg + 20 mg + 2.5 mg; 100 mg + 20 mg + 5 mg; 100 mg + 20 mg + 10 mg; 100 mg + 40 mg + 2.5 mg; 100 mg + 40 mg + 5 mg; 100 mg + 40 mg + 10 mg Indications: - Atherosclerotic chronic arterial occlusive disease - Chronic ischaemic heart disease - Cerebral ischaemic stroke Source: EML workbook import
MOQ: 1
Price on request
Acetylsalicylic Acid + Simvastatin + Ramipril + Atenolol + Hydrochlorothiazide image unavailable
QuoteAcetylsalicylic Acid + Simvastatin + Ramipril + Atenolol + Hydrochlorothiazide
Formulations: - Oral > Solid > tablet: 100 mg + 20 mg + 5 mg + 50 mg + 12.5 mg Indications: - Atherosclerotic chronic arterial occlusive disease - Chronic ischaemic heart disease - Cerebral ischaemic stroke Source: EML workbook import
MOQ: 1
Price on request
Atorvastatin + Perindopril + Amlodipine
Formulations: - Oral > Solid > tablet: 20 mg + 5 mg + 5 mg; 20 mg + 10 mg + 10 mg; 40 mg + 5 mg + 5 mg; 40 mg + 10 mg + 10 mg Indications: - Atherosclerotic chronic arterial occlusive disease - Chronic ischaemic heart disease - Cerebral ischaemic stroke Source: EML workbook import
MOQ: 1
Price on request
Abacavir + Dolutegravir + Lamivudine
Formulations: - Oral > Solid > tablet: 60 mg (as sulfate) + 5 mg + 30 mg (dispersible, scored) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Abacavir + Lamivudine
Formulations: - Oral > Solid: 120 mg (as sulfate) + 60 mg tablet (dispersible, scored) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Dolutegravir + Lamivudine + Tenofovir
Formulations: - Oral > Solid: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.